448 related articles for article (PubMed ID: 26192239)
1. [Differential characteristics of AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC patients].
Sun L; Wang Y; Liu Y; Zhao Y; Zhang X; Wang Y; Zhao D; Zhang H; Ma Y
Zhonghua Gan Zang Bing Za Zhi; 2015 May; 23(5):343-9. PubMed ID: 26192239
[TBL] [Abstract][Full Text] [Related]
2. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342
[No Abstract] [Full Text] [Related]
3. Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis.
Zhu YJ; Li J; Liu YG; Jiang Y; Cheng XJ; Han X; Wang CY; Li J
World J Gastroenterol; 2023 Sep; 29(34):5075-5081. PubMed ID: 37753365
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.
Li BA; Liu J; Hou J; Tang J; Zhang J; Xu J; Song YJ; Liu AX; Zhao J; Guo JX; Chen L; Wang H; Yang LH; Lu J; Mao YL
World J Gastroenterol; 2015 Jan; 21(1):283-91. PubMed ID: 25574103
[TBL] [Abstract][Full Text] [Related]
5. [Immunological characteristics of primary biliary cirrhosis patients].
Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
[TBL] [Abstract][Full Text] [Related]
6. Primary biliary cirrhosis and hepatitis C virus infection.
Floreani A; Baragiotta A; Leone MG; Baldo V; Naccarato R
Am J Gastroenterol; 2003 Dec; 98(12):2757-62. PubMed ID: 14687829
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome].
Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851
[TBL] [Abstract][Full Text] [Related]
8. Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies.
Öztürk Ö; Dos Santos Duarte SD; Balaban HY; Şimşek H; Şener B
Turk J Med Sci; 2022 Apr; 52(5):1697-1703. PubMed ID: 36422475
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features of patients with primary biliary cirrhosis and anti-SP100 autoantibody positivity].
Tang YM; Bao WM; You LY; Jiang HJ; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):359-62. PubMed ID: 24025137
[TBL] [Abstract][Full Text] [Related]
10. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
Twaddell WS; Lefkowitch J; Berk PD
Semin Liver Dis; 2008 Feb; 28(1):128-34. PubMed ID: 18293283
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis.
Hu C; Deng C; Song G; Zhang W; Zhang S; Li X; Li P; Zhang F; Li Y
Dig Dis Sci; 2011 Nov; 56(11):3357-63. PubMed ID: 21660486
[TBL] [Abstract][Full Text] [Related]
12. Clinical correlation of antimitochondrial antibodies.
Zuber MA; Recktenwald C
Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
[TBL] [Abstract][Full Text] [Related]
13. Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients.
Zografos TA; Gatselis N; Zachou K; Liaskos C; Gabeta S; Koukoulis GK; Dalekos GN
World J Gastroenterol; 2012 Sep; 18(34):4721-8. PubMed ID: 23002341
[TBL] [Abstract][Full Text] [Related]
14. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
[TBL] [Abstract][Full Text] [Related]
16. Characterization of overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis according to antimitochondrial antibodies status.
Alric L; Thebault S; Selves J; Peron JM; Mejdoubi S; Fortenfant F; Vinel JP
Gastroenterol Clin Biol; 2007 Jan; 31(1):11-6. PubMed ID: 17273127
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features of patients with primary biliary cirrhosis].
He L; Lai Y; Lai L; Luo K; Wang W; Tian Y; Gong G; Zhang M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 40(12):1333-9. PubMed ID: 26739075
[TBL] [Abstract][Full Text] [Related]
19. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody.
Arakawa Y; Amaki S; Miyakawa H; Sakai T; Gotou I; Tanaka N; Moriyama M; Iwasaki A; Sugitani M; Arakawa Y
J Gastroenterol; 2004; 39(5):490-5. PubMed ID: 15175950
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological analysis of anti-mitochondrial antibody negative primary biliary cholangitis-autoimmune hepatitis overlap syndrome].
Tan XY; Miao Q; Chen XY
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):376-380. PubMed ID: 31177663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
